Clinical trial
Phase II Evaluation of Targretin Capsules in Patients With AIDS-Related Kaposi's Sarcoma
NCT00002212 is registered in ClinicalTrials.gov with Ligand Pharmaceuticals as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase II Evaluation of Targretin Capsules in Patients With AIDS-Related Kaposi's Sarcoma
- Lead sponsor
- Ligand Pharmaceuticals
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- Not reported
- Completion date
- Not reported
- Enrollment
- 27
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.